Kodiak Sciences Financials

KOD Stock  USD 6.40  0.40  5.88%   
Based on the key indicators related to Kodiak Sciences' liquidity, profitability, solvency, and operating efficiency, Kodiak Sciences is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March. At present, Kodiak Sciences' Other Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Property Plant And Equipment Net is expected to grow to about 211.3 M, whereas Short and Long Term Debt Total is forecasted to decline to about 53.6 M. Key indicators impacting Kodiak Sciences' financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio11.046.24
Way Up
Slightly volatile
The financial analysis of Kodiak Sciences is a critical element in measuring its lifeblood. Investors should not minimize Kodiak Sciences' ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.

Net Income

(222.72 Million)

  
Please note, the presentation of Kodiak Sciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Kodiak Sciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Kodiak Sciences' management manipulating its earnings.

Kodiak Sciences Stock Summary

Kodiak Sciences competes with Reviva Pharmaceuticals, Cognition Therapeutics, Transcode Therapeutics, Assembly Biosciences, and Instil Bio. Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California. Kodiak Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 101 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS50015M1099
CUSIP50015M109
LocationCalifornia; U.S.A
Business Address1200 Page Mill
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitekodiak.com
Phone650 281 0850
CurrencyUSD - US Dollar

Kodiak Sciences Key Financial Ratios

Kodiak Sciences Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets1.1B904.2M666.6M479.4M551.3M492.8M
Other Current Liab18.0M44.4M23.5M18.4M21.1M17.0M
Other Liab530K295K100.1M100.2M115.2M120.9M
Net Tangible Assets345.4M860.8M663.3M436.2M501.6M358.7M
Net Debt(867.0M)(651.5M)(102.7M)(203.9M)(183.5M)(192.7M)
Retained Earnings(291.2M)(558.2M)(892.0M)(1.2B)(1.0B)(985.4M)
Accounts Payable8.6M12.4M9.1M13.6M15.6M16.4M
Cash944.4M731.5M190.4M285.5M328.3M338.7M
Other Assets0.068.7M61.3M64.9M74.6M78.3M
Capital Surpluse503.5M1.2B1.2B1.3B1.5B1.6B
Other Current Assets6.1M6.6M7.1M3.8M4.4M4.0M
Total Liab206.6M240.9M230.5M213.6M245.6M142.4M
Total Current Assets972.0M734.8M486.0M289.3M332.7M402.0M
Short Term Debt4.7M7.9M19.9M9.8M11.2M6.7M
Net Invested Capital860.8M663.3M436.2M265.8M305.6M408.5M
Net Working Capital940.6M670.1M433.5M247.6M284.7M423.9M

Kodiak Sciences Key Income Statement Accounts

202020212022202320242025 (projected)
Net Interest Income2.9M276K7.1M16.7M19.2M20.2M
Interest Income2.9M298K7.1M16.7M19.2M20.2M
Interest Expense25K22K18K13K11.7K11.1K
Gross Profit(4.2M)(8.7M)(11.0M)(25.9M)(23.4M)(22.2M)
Operating Income(136.0M)(267.1M)(341.4M)(277.3M)(249.6M)(237.1M)
Ebit(133.1M)(267.0M)(333.8M)(277.3M)(249.6M)(237.1M)
Research Development107.4M217.3M267.6M206.3M237.2M122.5M
Ebitda(128.9M)(258.3M)(322.8M)(259.0M)(233.1M)(221.5M)
Cost Of Revenue4.2M8.7M11.0M25.9M29.8M31.3M
Income Before Tax(133.1M)(267.0M)(333.8M)(260.5M)(234.4M)(222.7M)
Net Income(133.1M)(267.0M)(333.8M)(260.5M)(234.4M)(222.7M)
Income Tax Expense(638K)2.7M(153.6K)7.3M8.4M8.9M

Kodiak Sciences Key Cash Accounts

202020212022202320242025 (projected)
Investments111.8M24.5M(289.2M)249.2M286.6M300.9M
Change In Cash738.8M(212.9M)(541.1M)95.1M85.6M89.8M
Free Cash Flow(90.4M)(245.6M)(253.8M)(195.6M)(176.0M)(184.9M)
Depreciation4.2M8.7M11.0M25.9M29.8M31.3M
Other Non Cash Items49K53K(1.6M)(840K)(756K)(718.2K)
Capital Expenditures7.0M63.3M47.4M41.4M47.6M50.0M
Net Income(133.1M)(267.0M)(333.8M)(260.5M)(234.4M)(222.7M)
End Period Cash Flow950.7M737.8M196.8M285.5M328.3M341.3M
Change To Netincome6.1M30.7M61.5M105.4M121.2M127.3M

Kodiak Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Kodiak Sciences's current stock value. Our valuation model uses many indicators to compare Kodiak Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kodiak Sciences competition to find correlations between indicators driving Kodiak Sciences's intrinsic value. More Info.
Kodiak Sciences is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At present, Kodiak Sciences' Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Kodiak Sciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Kodiak Sciences Systematic Risk

Kodiak Sciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Kodiak Sciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Kodiak Sciences correlated with the market. If Beta is less than 0 Kodiak Sciences generally moves in the opposite direction as compared to the market. If Kodiak Sciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Kodiak Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Kodiak Sciences is generally in the same direction as the market. If Beta > 1 Kodiak Sciences moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Kodiak Sciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Kodiak Sciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Kodiak Sciences growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.043

At present, Kodiak Sciences' Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting.

Kodiak Sciences February 1, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Kodiak Sciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Kodiak Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Kodiak Sciences based on widely used predictive technical indicators. In general, we focus on analyzing Kodiak Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Kodiak Sciences's daily price indicators and compare them against related drivers.

Complementary Tools for Kodiak Stock analysis

When running Kodiak Sciences' price analysis, check to measure Kodiak Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kodiak Sciences is operating at the current time. Most of Kodiak Sciences' value examination focuses on studying past and present price action to predict the probability of Kodiak Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kodiak Sciences' price. Additionally, you may evaluate how the addition of Kodiak Sciences to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Equity Valuation
Check real value of public entities based on technical and fundamental data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance